Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 243 results found since Jan 2013.
Hanger: Incidence of HPV-associated cancers on the rise
The incidence of human papillomavirus–associated cancers is increasing in the United States, but many of these cases could be prevented by the HPV vaccine, investigators from the Centers for Disease Control and Prevention report.
Between 2008 and 2012 the incidence of HPV-associated cancers was...
Source: Skin and Allergy News - July 12, 2016 Category: Dermatology Source Type: news
Incidence of HPV-associated cancers on the rise
The incidence of human papillomavirus–associated cancers is increasing in the United States, but many of these cases could be prevented by the HPV vaccine, investigators from the Centers for Disease Control and Prevention report.
Between 2008 and 2012 the incidence of HPV-associated cancers was...
Source: Skin and Allergy News - July 12, 2016 Category: Dermatology Source Type: news
ACS Recommends HPV Vaccine for Girls and Boys Ages 11-12ACS Recommends HPV Vaccine for Girls and Boys Ages 11-12
The American Cancer Society has endorsed CDC guidelines for HPV vaccinations that recommend girls and boys ages 11 to 12 should receive the vaccine. Medscape Medical News
Source: Medscape Allergy Headlines - July 19, 2016 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
ACS Recommends HPV Vaccine for Girls and Boys Ages 11-12 ACS Recommends HPV Vaccine for Girls and Boys Ages 11-12
The American Cancer Society has endorsed CDC guidelines for HPV vaccinations that recommend girls and boys ages 11 to 12 should receive the vaccine. Medscape Medical News
Source: Medscape Allergy Headlines - July 19, 2016 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
The goal of harnessing the immune system to fight cancer is not new; it dates back 125 years to when William Coley advocated that the body's response to infection could have anti-tumoural effects.1 However, decades of efforts using vaccines and immune stimulant therapies to harness the immune system to fight tumours have had limited success and at times have been fraught with serious adverse outcomes. Recently, drugs blocking negative immune checkpoint pathways have shown remarkable clinical activity in various solid tumours.2 Several agents targeting two such negative checkpoints, the programmed death-1 (PD-1) pathwa...
Source: Annals of the Rheumatic Diseases - December 8, 2016 Category: Rheumatology Authors: Calabrese, L., Velcheti, V. Tags: Immunology (including allergy), Inflammation, Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis Editorials Source Type: research
Our news predictions for 2017
Climate change continues to impact on public health
Despite what many commenters have said in 2016, climate change is real and is ongoing. That's the thing about science. Just because you don't believe in it, it doesn't go away.
In 2016 we have seen evidence of the impact of climate change in a number of different ways.
There was an anthrax outbreak in northern Russia as warm weather caused the release of previously frozen deadly anthrax spores.
And many experts think that the spread of the Zika virus across much of the Americas was made possible, in part, by changes in temperature that created environments in which the ...
Source: NHS News Feed - December 30, 2016 Category: Consumer Health News Tags: QA articles Special reports Source Type: news
Developing immunotherapies for childhood cancer
Introduction The development of immune-based treatment (immunotherapy) for childhood cancer is a rapidly advancing field with impressive results already achieved in children with leukaemia.1 2 For cancers resistant to conventional treatments, harnessing the power and specificity of the immune system to fight cancer is one of several current avenues of research. The immune system is essential for controlling cancer progression by continual surveillance and elimination of transformed cells. This protective process is hindered by the ability of cancer cells to develop mechanisms enabling them to ‘hide’ from immune...
Source: Archives of Disease in Childhood - Education and Practice - May 16, 2017 Category: Pediatrics Authors: Capsomidis, A., Anderson, J. Tags: Oncology, Immunology (including allergy), Drugs: infectious diseases, Vaccination / immunisation, Dermatology, Guidelines Research in practice Source Type: research
Personalized Vaccines Hold Cancer at Bay in Two Early Trials Personalized Vaccines Hold Cancer at Bay in Two Early Trials
A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.Reuters Health Information
Source: Medscape Allergy Headlines - July 6, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Cholera Vaccination May Lower Risk of Death From Colorectal Cancer Cholera Vaccination May Lower Risk of Death From Colorectal Cancer
Cholera vaccination after a diagnosis of colorectal cancer (CRC) is associated with reduced risks of death from CRC and from any cause, according to data from a Swedish study.Reuters Health Information
Source: Medscape Allergy Headlines - October 11, 2017 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
An X-linked agammaglobulinemia contiguous gene syndrome with metachronous coprimary testicular cancers
This report describes an association between the X-linked agammaglobulinemia (XLA) contiguous BTK, TIMM8A, TAF7L gene syndrome and repeated testicular cancers. A previous Annals report described an association of XLA and Mohr-Tranebjaerg syndrome (MTS) in this now 28-year-old man first diagnosed at 11 months of age.1 The patient was diagnosed with XLA when he presented with acute bilateral flaccid paralysis subsequent to a varicella vaccination and was found to have hypogammaglobinemia (IgG,
Source: Annals of Allergy, Asthma and Immunology - January 4, 2018 Category: Allergy & Immunology Authors: Marcus Shaker, Ting-Jia Lorigiano, Alexandra Lucas, Sergey Devitskiy, Youdinghuan Chen, Brock Christensen Tags: Letter Source Type: research
Hepatitis B vaccine non-responders: possible mechanisms and solutions
Hepatitis B (HBV) is a viral illness that chronically infects 240 million people worldwide, leads to cirrhotic liver disease, and increases risk of hepatocellular carcinoma. The HBV vaccine has decreased HBV infection and along with human papilloma virus (HPV) vaccine are the only vaccines that prevent cancer. Despite the effectiveness of HBV vaccine, some populations do not develop protective responses. The risk groups for poor response include those with immunosuppression or dialysis-dependent, end-stage renal disease.
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford Tags: Review Source Type: research
Newly described human antibody prevents malaria in mice
(NIH/National Institute of Allergy and Infectious Diseases) Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine if the antibody can provide short-term protection against malaria, and also may aid in vaccine design. NIAID investigators led the research with colleagues at the Fred Hutchinson Cancer Research Center. Currently, there is no highly effective, long-lasting vaccine to prevent malaria.
Source: EurekAlert! - Infectious and Emerging Diseases - March 19, 2018 Category: Infectious Diseases Source Type: news
Transdermal immunomodulation: Principles, advances, and perspectives.
Abstract
Immunomodulation, manipulation of the immune responses towards an antigen, is a promising strategy to treat cancer, infectious diseases, allergies, and autoimmune diseases, among others. Unique features of the skin including the presence of tissue-resident immune cells, ease of access and connectivity to other organs makes it a unique target organ for immunomodulation. In this review, we summarize advances in transdermal delivery of agents for modulating the immune responses for vaccination as well as tolerization. The biological foundation of skin-based immunomodulation and challenges in its implementati...
Source: Advanced Drug Delivery Reviews - March 28, 2018 Category: Drugs & Pharmacology Authors: Zhao Z, Ukidve A, Dasgupta A, Mitragotri S Tags: Adv Drug Deliv Rev Source Type: research
Hepatitis B vaccine non-responders: possible mechanisms and solutions
Hepatitis B (HBV) is a viral illness that chronically infects 240 million people worldwide, leads to cirrhotic liver disease, and increases risk of hepatocellular carcinoma. The HBV vaccine has decreased HBV infection and along with human papilloma virus (HPV) vaccine are the only vaccines that prevent cancer. Despite the effectiveness of HBV vaccine, some populations do not develop protective responses. The risk groups for poor response include those with immunosuppression or dialysis-dependent, end-stage renal disease.
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford Tags: Review Source Type: research
Hepatitis B vaccine nonresponders
Hepatitis B (HBV) is a viral illness that chronically infects 240 million people worldwide, leads to liver disease, and increases risk of hepatocellular carcinoma. The HBV vaccine has decreased HBV infection, and it and the human papilloma virus vaccine are the only vaccines that prevent cancer. Despite the effectiveness of the HBV vaccine, some populations do not develop protective responses. The risk groups for poor response include those with immunosuppression or dialysis-dependent, end-stage renal disease.
Source: Annals of Allergy, Asthma and Immunology - March 19, 2018 Category: Allergy & Immunology Authors: Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford Tags: Review Source Type: research
